Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
出版年份 2018 全文链接
标题
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-09-20
DOI
10.3389/fmicb.2018.02231
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection
- (2018) Steven A. Cowman et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mycobacterium abscessus Smooth and Rough Morphotypes Form Antimicrobial-Tolerant Biofilm Phenotypes but Are Killed by Acetic Acid
- (2018) Gillian Clary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium avium complex pulmonary disease
- (2018) Leah Lande et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease
- (2018) Hayoung Choi et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The Many Lives of Nontuberculous Mycobacteria
- (2018) Tiffany A. Claeys et al. JOURNAL OF BACTERIOLOGY
- Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis
- (2018) Petra Zimmermann et al. JOURNAL OF INFECTIOUS DISEASES
- Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions
- (2018) Diana Angelica Aguilar-Ayala et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Effect of Mycobacterium tuberculosis infection on adipocyte physiology
- (2018) Janeesh Plakkal Ayyappan et al. MICROBES AND INFECTION
- Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease
- (2018) Daniel P. O’Brien et al. PLoS Neglected Tropical Diseases
- MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
- (2018) Wei Li et al. Frontiers in Microbiology
- Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
- (2018) Davide Caimmi et al. Open Forum Infectious Diseases
- Discovery of benzothiazole amides as potent antimycobacterial agents
- (2018) James Graham et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs
- (2017) D. Rebecca Prevots et al. EUROPEAN RESPIRATORY JOURNAL
- Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41)
- (2017) Natalia F G de Carvalho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study
- (2017) Jakko van Ingen et al. LANCET INFECTIOUS DISEASES
- Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward
- (2017) Stacey L. Martiniano et al. PEDIATRIC PULMONOLOGY
- Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
- (2017) Jian Liang Low et al. Frontiers in Microbiology
- Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
- (2017) G.B. Sigal et al. EBioMedicine
- Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
- (2016) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
- (2016) M. Alexandra Lake et al. BMC Medicine
- Nontuberculous mycobacterial infections in cystic fibrosis
- (2016) Jerry A. Nick et al. CURRENT OPINION IN PULMONARY MEDICINE
- Mortality among patients with pulmonary non-tuberculous mycobacteria disease
- (2016) M. Fleshner et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target
- (2016) Giovanna Poce et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus
- (2016) Christian Dupont et al. MOLECULAR MICROBIOLOGY
- Structure–Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions
- (2016) Jiuyu Liu et al. ACS Infectious Diseases
- Structure–Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis
- (2016) Juan Manuel Belardinelli et al. ACS Infectious Diseases
- Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
- (2015) Beatriz E. Ferro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Treatment of Rapidly Growing Mycobacterial Infections
- (2015) Shannon H. Kasperbauer et al. CLINICS IN CHEST MEDICINE
- Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria
- (2015) D. Rebecca Prevots et al. CLINICS IN CHEST MEDICINE
- Analysis of a panel of rapidly growing mycobacteria for resistance to aldehyde-based disinfectants
- (2014) Mary Ann De Groote et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
- (2014) Sasha J. Rose et al. PLoS One
- Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
- (2013) Ashwin S. Dharmadhikari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MmpL3 a potential new target for development of novel anti-tuberculosis drugs
- (2013) Geetha Vani Rayasam EXPERT OPINION ON THERAPEUTIC TARGETS
- TMC207 becomes bedaquiline, a new anti-TB drug
- (2013) Juan Carlos Palomino et al. Future Microbiology
- GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus
- (2013) M. A. De Groote et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
- (2013) Giovanna Poce et al. PLoS One
- Ecology of Nontuberculous Mycobacteria—Where Do Human Infections Come from?
- (2013) Joseph Falkinham SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary Delivery
- (2012) Mercedes Gonzalez-Juarrero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
- (2012) Katherine A Sacksteder et al. Future Microbiology
- Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
- (2012) Scott G. Franzblau et al. TUBERCULOSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started